Clinical Trials Logo
  1. Home
  2. Osteopenia
  3. NCT04377230
  4. Details
NCT04377230 Clinical Trial

BP Limb Length of 60cm vs 100cm in Roux-en-Y Gastric Bypass

Osteopenia Clinical Trial

Official title:
Impact of Biliopancreatic Limb Length of 60cm vs 100cm in Roux-en-Y Gastric Bypass on Bone Mineral Density 2 Years After Surgery

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT04377230
Other study ID # Garcilaso-Mex 20-3
Secondary ID
Status Not yet recruiting
Phase Phase 3
First received
Last updated
Start date May 7, 2020
Est. completion date May 1, 2022

Study information
Verified date May 2020
Source Hospital General Universitario Elche
Contact Carolina LLavero Garrido
Phone 649593020
Email carolinallavero@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients will be randomized into 2 groups:

- Group 60: Patients will undergo a Roux-en-Y gastric bypass with a Biliopancreatic limb length of 60cm

- Group 100: Patients will undergo a Roux-en-Y gastric bypass with a Biliopancreatic limb length of 100cm

Bone mineral density will be evaluated before surgery and 2 years after it.

Description:

Patients will be randomized into 2 groups:

- Group 60: Patients will undergo a Roux-en-Y gastric bypass with a Biliopancreatic limb length of 60cm

- Group 100: Patients will undergo a Roux-en-Y gastric bypass with a Biliopancreatic limb length of 100cm Alimentary limb will be constant in both groups (150cm length)

Bone mineral density will be evaluated before surgery and 2 years after it, by means of X ray absorptiometry (DEXA). Changes in bone mineral density in lumbar column will be assessed.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 200
Est. completion date May 1, 2022
Est. primary completion date May 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Body mass index >40 Kg/m2

- Body mass index >35 Kg/m2 associated to obesity related comorbidities

Exclusion Criteria:

- Bone pathologies

- Active neoplasms

- Disorders in calcium or vitamin D metabolism

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• biliopancreatic limb length of 60cm.
Roux-en- Y gastric bypass will be performed with a biliopancreatic limb length of 60cm.
• biliopancreatic limb length of 100cm.
Roux-en- Y gastric bypass will be performed with a biliopancreatic limb length of 100cm.

Locations
Country Name City State
n/a

Sponsors (2)
Lead Sponsor Collaborator
Hospital General Universitario Elche Instituto de Seguridad Social del Estado de Mexico y Municipios

Outcome
Type Measure Description Time frame Safety issue
Primary Bone mineral density Bone mineral density will be evealuated by absorptiometry at the level of lumbar column 2 years after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT04754711 - Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition N/A
Active, not recruiting NCT05066477 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Bone Mass Among Osteopenic Women N/A
Terminated NCT01902186 - Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir Phase 4
Completed NCT01439139 - Bone UltraSonic Scanner (BUSS): Validation Study N/A
Not yet recruiting NCT01397838 - Safety Study of an Oral Pro-boneTM, Administered to Post Menopausal Osteopenic Women Phase 1
Completed NCT01222026 - Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate Phase 4
Completed NCT01152580 - Melatonin Osteoporosis Prevention Study Phase 1
Completed NCT00789425 - Investigating the Effect of Standardized Olive Extract on Bone Turnover Markers in Postmenopausal Women Phase 2
Completed NCT00655681 - Prevention of Post Operative Bone Loss in Children N/A
Completed NCT00463268 - Osteoporosis Prevention With Low Dose Alendronate Phase 3
Completed NCT00798473 - Zoledronate for Osteopenia in Pediatric Crohn's Phase 3
Active, not recruiting NCT00076050 - Using Soy Estrogens to Prevent Bone Loss and Other Menopausal Symptoms Phase 3
Completed NCT00226031 - Optimal Management of Women With Wrist Fractures N/A
Enrolling by invitation NCT04752098 - A Study to Assess Metabolic Bone Disease of Prematurity Using an Acoustic Method N/A
Completed NCT04720833 - Effect of Dried Plum on Bone and Markers of Bone Status in Men N/A
Recruiting NCT05541432 - Finding the Optimal Resistance Training Intensity For Your Bones N/A
Active, not recruiting NCT05405894 - Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation
Completed NCT05457036 - Evaluation of the Effect of Spry Belt Treatment on Bone Turnover Marker Profile N/A
Completed NCT04040010 - The Effects of Bovine Colostrum in Bone Metabolism in Humans N/A
Completed NCT02731820 - Efficacy of Potassium Citrate in the Treatment of Postmenopausal Osteopenia N/A